Skip to content
★ Sign in to follow
TM

Themis Medicare Limited Stock: price and insider trades · India

IN·Mcap ₹9.1BHealth Care

Themis Medicare Limited: what insiders have been doing

Themis Medicare Limited is a Health Care company. Its directors and officers file their transactions with SEBI (PIT + SAST). Between 30 October 2025 and 30 October 2026, 2 insiders published 4 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

Insider buying of Themis Medicare Limited has been absent for the past year. The median gap between trade and publication is zero days: most filings appear on the same day. That lag is the time during which only the insider knows about the trade.

For context, the typical company on the same exchange (median of 1,899 companies) published 4 filings over the same period, against 4 filings here. The full history, which starts in 2021, counts no purchases against 15 sales.

For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and EssilorLuxottica. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.

Insider Decl.
19
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€18,809
15 ops. · all time

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 21,308 of 26,912 companies
31.3
score / 100
Value
23
Quality
40
FCF yld-0.9%
Earn yld0.1%
EV/EBITDA49.2x
ROE0.3%
Gross mgn61%
Net mgn0.3%
Debt/EBITDA4.7x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended March 2026 · cache

₹97.52
Analyst consensus
·
Income statement
Revenue₹3.4B
Gross profit₹2.1B61% margin
EBITDA₹211.4M6% margin
Net income₹11.4M12.1% margin
Valuation
PER (trailing)23.2x
P/Book2.3x
Beta0.55
Balance sheet & cash
Market cap₹9.1B
Total debt₹1B
Free Cash Flow-₹81.4M
Debt / Equity25%
Profitability & ownership
ROE0.3%
ROA-1.0%
% insiders48.4%
% institutions0.0%
Last declaration on 30 October 2026
Declarations19 total
  • ●
    Related company / holdingExecutives
    0SEBI
    1,500,000 shares-CreationSEBI:677dcb602fa27f6482abb80559703cf94c93228d
  • ●
    Related company / holdingExecutives
    0SEBI
    2,500,000 shares-CreationSEBI:424c77dd19d603505e92d3d728425c0bdc9b2905
  • ●
    Related company / holdingExecutives
    0SEBI
    3,000,000 shares-CreationSEBI:04eb86c02d1d135ef8170e2c5526ba129162d0b3
  • ●
    Related company / holdingExecutives
    0SEBI
    25,317,620 shares-CreationSEBI:61dd3728f4e57b30e24daacf0a98f91f891a24d5
  • ▼
    Executives
    44,033 INR2SEBI
    33 shares@ ₹1,334.33332.7% of flowEquity SharesSEBI:d58ae75095e3ec1dfaadf558a9355be4007386c5
  • ▼
    Executives
    136,005 INR3SEBI
    100 shares@ ₹1,360.058.2% of flowEquity SharesSEBI:8f6e0eaf4c2b19fe4468db69fc98f1db91bc39c1
  • ▼
    Executives
    623,996 INR6SEBI
    467 shares@ ₹1,336.179937.7% of flowEquity SharesSEBI:a7ca5d4642e7a14c44052740e428986b3fa6d44e
  • ▼
    Executives
    270,400 INR4SEBI
    200 shares@ ₹1,352.0016.3% of flowEquity SharesSEBI:30c86bf2e99db582c521469e62bcde937d809130
  • ▼
    Executives
    94,901 INR3SEBI
    136 shares@ ₹697.80150.0012% mcap5.7% of flowEquity SharesSEBI:bf5880fc645022b10a38333cfb6af3126059bd6e
  • ▼
    Executives
    70,010 INR2SEBI
    100 shares@ ₹700.100.0009% mcap4.2% of flowEquity SharesSEBI:203f5413cda1d267c77a7224f74863d7789fa354
  • ▼
    Executives
    71,545 INR2SEBI
    100 shares@ ₹715.450.0009% mcap4.3% of flowEquity SharesSEBI:0f5a9d489ed6097913c18a214ac29f8fc45f4081
  • ▼
    Executives
    70,800 INR2SEBI
    100 shares@ ₹708.000.0009% mcap4.3% of flowEquity SharesSEBI:9c2750f07f8ee2e7329e463a79538e24f3b7d254
  • ▼
    Executives
    71,350 INR2SEBI
    100 shares@ ₹713.500.0009% mcap4.3% of flowEquity SharesSEBI:7851e255655fdd1a521d902d23cd9b4cfeaf3d77
  • ▼
    Executives
    80,840 INR2SEBI
    100 shares@ ₹808.400.0010% mcap4.8% of flowEquity SharesSEBI:53688fae5f0cf99d44270d190ac104a5653a6186
  • ▼
    Executives
    123,349 INR3SEBI
    155 shares@ ₹795.800.0016% mcap7.4% of flowEquity SharesSEBI:f3ca661b1c4260cf36ec6df2086d3b71fb1b675a
  • ▼
    Executives
    762 INR2SEBI
    200 shares@ ₹3.810.0000% mcap0.0% of flowEquity SharesSEBI:e6333f5c9d000de056e9fa77dc5234e5ecec2cae
  • ▼
    Executives
    737 INR2SEBI
    300 shares@ ₹2.45670.0000% mcap0.0% of flowEquity SharesSEBI:bf638f3d8ce313004548b72080bd4fd6203e270f
  • ▼
    Executives
    641 INR2SEBI
    300 shares@ ₹2.13670.0000% mcap0.0% of flowEquity SharesSEBI:aef5abfeab74e8d803fc7c4541ba2ecee853d643
  • ▼
    Executives
    643 INR2SEBI
    200 shares@ ₹3.2150.0000% mcap0.0% of flowEquity SharesSEBI:58a76e1d978156ebe542371565bc20a9d37dc23b

19 of 19 declarations

About Themis Medicare Limited

Themis Medicare Limited is a company operating in the healthcare and pharmaceutical sector. It is listed on the XBOM market.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations